These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 37044200)

  • 21. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An insight into thermodynamic relationship between polymorphic forms of efavirenz.
    Chadha R; Arora P; Saini A; Singh Jain D
    J Pharm Pharm Sci; 2012; 15(2):234-51. PubMed ID: 22579003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thermodynamic stability considerations for isostructural dehydrates.
    Murphy BJ; Casteel MJ; Samas B; Krzyzaniak JF
    J Pharm Sci; 2012 Apr; 101(4):1486-95. PubMed ID: 22262468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase transformation in conformational polymorphs of nimesulide.
    Sanphui P; Sarma B; Nangia A
    J Pharm Sci; 2011 Jun; 100(6):2287-99. PubMed ID: 21491446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization and interconversion of polymorphs of premafloxacin, a new quinolone antibiotic.
    Schinzer WC; Bergren MS; Aldrich DS; Chao RS; Dunn MJ; Jeganathan A; Madden LM
    J Pharm Sci; 1997 Dec; 86(12):1426-31. PubMed ID: 9423158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solid state characterization of E2101, a novel antispastic drug.
    Kushida I; Ashizawa K
    J Pharm Sci; 2002 Oct; 91(10):2193-202. PubMed ID: 12226846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solid state characterization of mometasone furoate anhydrous and monohydrate forms.
    Chen XS; Carillo M; Curtis Haltiwanger R; Bradley P
    J Pharm Sci; 2005 Nov; 94(11):2496-509. PubMed ID: 16200563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphs and hydrates of acyclovir.
    Lutker KM; Quiñones R; Xu J; Ramamoorthy A; Matzger AJ
    J Pharm Sci; 2011 Mar; 100(3):949-63. PubMed ID: 21280051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and characterization of polymorphs for an LTD4 antagonist, RG 12525.
    Carlton RA; Difeo TJ; Powner TH; Santos I; Thompson MD
    J Pharm Sci; 1996 May; 85(5):461-7. PubMed ID: 8742935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and selective crystallization of famotidine polymorphs.
    Lu J; Wang XJ; Yang X; Ching CB
    J Pharm Sci; 2007 Sep; 96(9):2457-68. PubMed ID: 17518361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal polymorphs of barbital: news about a classic polymorphic system.
    Zencirci N; Griesser UJ; Gelbrich T; Apperley DC; Harris RK
    Mol Pharm; 2014 Jan; 11(1):338-50. PubMed ID: 24283960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One-solvent polymorph screen of carbamazepine.
    Getsoian A; Lodaya RM; Blackburn AC
    Int J Pharm; 2008 Feb; 348(1-2):3-9. PubMed ID: 17945448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphism of Indomethacin in Semicrystalline Dispersions: Formation, Transformation, and Segregation.
    Van Duong T; Lüdeker D; Van Bockstal PJ; De Beer T; Van Humbeeck J; Van den Mooter G
    Mol Pharm; 2018 Mar; 15(3):1037-1051. PubMed ID: 29307188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New Findings on the Crystal Polymorphism of Imepitoin.
    Bruni G; Capsoni D; Pellegrini A; Altomare A; Coduri M; Ferrara C; Galinetto P; Molteni R
    Molecules; 2024 Apr; 29(8):. PubMed ID: 38675544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salt formation improved the properties of a candidate drug during early formulation development.
    Sigfridsson K; Ahlqvist M; Lindsjö M; Paulsson S
    Eur J Pharm Sci; 2018 Jul; 120():162-171. PubMed ID: 29730322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystallinity, hygroscopicity and dissolution of moricizine hydrochloride hemihydrate.
    Wu LS; Gerard C; Koval C; Rowe S; Hussain MA
    J Pharm Biomed Anal; 1994 Aug; 12(8):1043-6. PubMed ID: 7819378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural Properties, Order-Disorder Phenomena, and Phase Stability of Orotic Acid Crystal Forms.
    Braun DE; Nartowski KP; Khimyak YZ; Morris KR; Byrn SR; Griesser UJ
    Mol Pharm; 2016 Mar; 13(3):1012-29. PubMed ID: 26741914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystal forms of the hydrogen oxalate salt of o-desmethylvenlafaxine.
    Dichiarante E; Curzi M; Giaffreda SL; Grepioni F; Maini L; Braga D
    J Pharm Pharmacol; 2015 Jun; 67(6):823-9. PubMed ID: 25644936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solution-mediated phase transformation of anhydrous to dihydrate carbamazepine and the effect of lattice disorder.
    Murphy D; Rodríguez-Cintrón F; Langevin B; Kelly RC; Rodríguez-Hornedo N
    Int J Pharm; 2002 Oct; 246(1-2):121-34. PubMed ID: 12270615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solid-state study of mepivacaine hydrochloride.
    Giannellini V; Bambagiotti-Alberti M; Bartolucci G; Bruni B; Coran SA; Costantino F; Di Vaira M
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):444-54. PubMed ID: 15950424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.